Capital Research Global Investors Gilead Sciences, Inc. Transaction History

Capital Research Global Investors

  • $466 Billion
  • Q4 2024

A detailed history of Capital Research Global Investors transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Capital Research Global Investors holds 57,946,228 shares of GILD stock, worth $6.25 Billion. This represents 1.15% of its overall portfolio holdings.

Number of Shares
57,946,228
Previous 61,799,671 6.24%
Holding current value
$6.25 Billion
Previous $5.18 Billion 3.33%
% of portfolio
1.15%
Previous 1.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$83.95 - $97.9 $323 Million - $377 Million
-3,853,443 Reduced 6.24%
57,946,228 $5.35 Billion
Q3 2024

Nov 13, 2024
BUY
$66.59 - $83.99 $91.4 Million - $115 Million
1,371,957 Added 2.27%
61,799,671 $5.18 Billion
Q2 2024

Aug 13, 2024
SELL
$63.15 - $72.88 $51.7 Million - $59.7 Million
-818,652 Reduced 1.34%
60,427,714 $4.15 Billion
Q1 2024

May 14, 2024
BUY
$71.58 - $87.29 $114 Million - $139 Million
1,589,240 Added 2.66%
61,246,366 $4.49 Billion
Q4 2023

Feb 13, 2024
BUY
$73.27 - $83.09 $128 Million - $145 Million
1,743,418 Added 3.01%
59,657,126 $4.83 Billion
Q3 2023

Nov 13, 2023
BUY
$73.94 - $80.67 $1.04 Million - $1.13 Million
14,039 Added 0.02%
57,913,708 $4.34 Billion
Q2 2023

Aug 11, 2023
SELL
$76.01 - $86.7 $28.8 Million - $32.8 Million
-378,438 Reduced 0.65%
57,899,669 $4.46 Billion
Q1 2023

May 15, 2023
BUY
$77.31 - $88.08 $284 Million - $324 Million
3,675,155 Added 6.73%
58,278,107 $4.84 Billion
Q4 2022

Feb 14, 2023
BUY
$62.32 - $89.47 $45.3 Million - $65.1 Million
727,482 Added 1.35%
54,602,952 $4.69 Billion
Q3 2022

Nov 14, 2022
SELL
$59.54 - $68.01 $125 Million - $143 Million
-2,100,510 Reduced 3.75%
53,875,470 $3.32 Billion
Q2 2022

Aug 15, 2022
BUY
$57.72 - $65.01 $1.42 Million - $1.6 Million
24,601 Added 0.04%
55,975,980 $3.46 Billion
Q1 2022

May 16, 2022
SELL
$57.92 - $72.58 $2.97 Billion - $3.72 Billion
-51,205,602 Reduced 47.79%
55,951,379 $3.33 Billion
Q4 2021

Feb 14, 2022
SELL
$64.88 - $73.64 $480 Million - $544 Million
-7,391,127 Reduced 6.45%
107,156,981 $7.78 Billion
Q3 2021

Nov 15, 2021
SELL
$67.69 - $73.03 $144 Million - $155 Million
-2,123,447 Reduced 1.82%
114,548,108 $8 Billion
Q2 2021

Aug 16, 2021
SELL
$63.47 - $69.35 $377 Million - $412 Million
-5,934,783 Reduced 4.84%
116,671,555 $8.03 Billion
Q1 2021

May 14, 2021
BUY
$60.0 - $68.46 $56 Million - $63.9 Million
933,939 Added 0.77%
122,606,338 $7.92 Billion
Q4 2020

Feb 12, 2021
BUY
$56.65 - $64.55 $258 Million - $294 Million
4,559,152 Added 3.89%
121,672,399 $7.09 Billion
Q3 2020

Nov 13, 2020
SELL
$62.1 - $78.08 $512 Million - $644 Million
-8,243,635 Reduced 6.58%
117,113,247 $7.4 Billion
Q2 2020

Aug 14, 2020
BUY
$72.34 - $84.0 $2.12 Billion - $2.47 Billion
29,374,563 Added 30.6%
125,356,882 $9.64 Billion
Q1 2020

May 15, 2020
BUY
$62.63 - $80.22 $680 Million - $870 Million
10,849,434 Added 12.74%
95,982,319 $7.18 Billion
Q4 2019

Feb 18, 2020
BUY
$61.62 - $67.78 $514 Million - $566 Million
8,343,863 Added 10.87%
85,132,885 $5.53 Billion
Q3 2019

Nov 14, 2019
SELL
$62.51 - $69.0 $310 Million - $342 Million
-4,959,665 Reduced 6.07%
76,789,022 $4.87 Billion
Q2 2019

Aug 14, 2019
BUY
$61.87 - $69.38 $220 Million - $247 Million
3,562,752 Added 4.56%
81,748,687 $5.52 Billion
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $352 Million - $395 Million
5,637,146 Added 7.77%
78,185,935 $5.08 Billion
Q4 2018

Feb 14, 2019
BUY
$60.54 - $79.0 $163 Million - $213 Million
2,693,821 Added 3.86%
72,548,789 $4.54 Billion
Q3 2018

Nov 14, 2018
BUY
$71.28 - $78.92 $914 Million - $1.01 Billion
12,818,301 Added 22.47%
69,854,968 $5.39 Billion
Q2 2018

Aug 14, 2018
BUY
$64.88 - $75.68 $914 Million - $1.07 Billion
14,093,328 Added 32.82%
57,036,667 $4.04 Billion
Q1 2018

May 15, 2018
BUY
$72.84 - $88.8 $774 Million - $943 Million
10,620,098 Added 32.86%
42,943,339 $3.24 Billion
Q4 2017

Feb 14, 2018
BUY
$71.15 - $83.52 $744 Million - $873 Million
10,454,610 Added 47.81%
32,323,241 $2.32 Billion
Q3 2017

Nov 14, 2017
BUY
$72.11 - $85.47 $1.58 Billion - $1.87 Billion
21,868,631
21,868,631 $1.77 Billion

Others Institutions Holding GILD

# of Institutions
2,101
Shares Held
987M
Call Options Held
8.73M
Put Options Held
9.63M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $135B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email